Unto Healthcare by Michelle Parker

08/07/2026

Discover the top natural remedies to keep on hand.

I post new health content every day. Follow so you don't miss it!

And for more on this topic, check out this video: https://drbrg.co/4osBpTp

Dr. Eric Berg, DC, not MD; information only

08/06/2026

For those interested in mhbot specifically in young children with neurological issues and Cerebralsy. This study focuses on using mhbot and just pressurized air.

In some cases less is more :

Published Studies from Dr Harchs website:

Of the 111 children diagnosed with CP (aged 4 to 12 years), only 75 were suitable for neuropsychological testing, assessing attention, working memory, processing speed, and psychosocial functioning. The children received 40 sessions of HBOT or sham treatment over a 2-month period. Children in the active-treatment group were exposed for 1 h to 100% oxygen at 1.75 atmospheres absolute (ATA), whereas the sham group received only air at 1.3 ATA. Children in both groups showed better self-control and significant improvements in auditory attention and visual working memory compared with the baseline.

However, no statistical difference was found between the two treatments. Furthermore, the sham group improved significantly on eight dimensions of the Conners’ Parent Rating Scale, whereas the active treatment group improved only on one dimension. Most of these positive changes persisted for 3 months. No improvements were observed in either group for verbal span, visual attention, or processing speed. Unfortunately, the Collet study increased the pressure to 1.75 ATA of 100% oxygen for 60 min (40 treatments) and to 1.3 ATA in the control group breathing air for 60 min, i.e., a 30% increase in oxygen for the controls.

This dose of HBOT had not been used previously in Cerebral Palsy patients and was possibly an overdose (Harch 2001) and likely inhibited the HBOT group’s gains. Evidence for this was seen in the GMFM data where five of the six scores increased in the HBOT group from immediate post HBOT testing to the 3-month retest versus three of six scores in the controls. Some of the negative effects of 1.75 ATA likely had worn off by this time. Results of the Collet study showed significant improvements in both groups, but no difference between groups. The serendipitous flaw in the study was the 1.3 ATA air control group, which also improved significantly. This underscored the fact that the ideal dose of HBOT is unknown in chronic pediatric brain injury, but it suggested that oxygen signaling may occur at very low pressures. Mild HBOT therapy can be effective in improving SPECT as well as attention and reaction times (Heuser & Uszler 2001).

08/06/2026

Hyperbaric Oxygen Therapy (HBOT) has the capacity to upregulate white blood cell function.

Your white blood cells use reactive oxygen species (free radical oxygen) as its ammunition to fight infection.

So, as we go into a chamber and get all of this extra oxygen, some of that oxygen can be used to help fuel the white blood cells (your immune system) to fight that infection better.

Particularly in chronic infections, the immune system gets very fatigued, and it's hard for the immune system to maintain the energy necessary to continue that fight, month after month, year after year.

HBOT has the capacity to really help rebuild and refuel that immune system to keep up the fight.

08/05/2026

08/05/2026

Vertigo if you are experiencing it, come try the hbot chamber

08/04/2026

Tuesday Teezers is all about sleep part 4

08/03/2026

If this is you, call for a Appointment. And start the journey to feeling better.

08/02/2026

A study published this year by Dr. Paul Harch, Director of Hyperbaric Medicine at LSU, and Bismarck Doctor Edward Fogarty, shows improved brain function in a woman who suffered from early-onset Alzheimer’s disease.

The PET scans show dramatic improvement in her brain function.

“A miraculous change!” said Ruthie Kostka, whose husband suffers from dementia.

Ruthie and her husband, Bob Kostka, formerly of Fargo, moved to Colorado in 2003.

She said Bob’s dementia had progressed to the point it was hard for him to carry on a conversation.

“Everything depends on communication — well, we didn’t have it for a year and a half, and the last nine months almost nothing at all,” said Ruthie.

Ruthie checked into hyperbaric treatment, debated the cost and decided it was a small price to pay.
Desperate, she bought a hyperbaric chamber and put it right in her home.

“We didn’t know what to expect: Would it take a year? Would it ever work?” said Ruthie.

“But, three days! This is the good part. He was in three times in a row. The following morning we did our coffee deal, visiting, and I’m thinking, ‘My gosh, I think we’re having a conversation.’ Bob said that machine is working and I knew it was.”
Ruthie said there was a dramatic improvement.

“Back walking and jogging, shoveling snow,” said Bob.
He said it’s changed his life and hers, his kids and his grandkids.

“Grandpa’s Grandpa again. He’s laughing and joking,” said Ruthie.
Bob wasn’t part of any fancy, published study.

“Oh it’s like a miracle,” said Ruthie.
Some experts said they still need to see more studies.

A spokesman for The Mayo Clinic, which lists Hyperbaric Oxygen Treatment, or HBOT, as a treatment for other diseases but not for Alzheimer’s, notes a single case report is, “not deemed sufficient grounds to recommend a therapy by our experts,” and that a larger series of studies would be needed.

They sent us this statement: “This is a very exciting time in Alzheimer’s disease and dementia research.

The Alzheimer’s Association is confident that better treatments, earlier detection and prevention strategies will be available in the foreseeable future. The speed with which those achievements occur is directly related to the commitment to Alzheimer’s and dementia research.”

Link to full article :

https://www.kxnet.com/news/local-news/new-hope-for-alzheimers-patients/?fbclid=IwAR0a2WM3qx63A6CbhFI-MJnBBvbwFtcOFxIZ-X_983Ky4DuVg7-FOgV43Vo

There’s new, very real, hope for Alzheimer’s and dementia patients. A study published this year by Dr. Paul Harch, Director of Hyperbaric Medicine at LSU, and Bismarck Doctor Edward Fog…

07/30/2026